Dorsey Wright & Associates’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
LCM
BCC
MFP
SSP
Dorsey Wright & Associates's ATEX Position: Q3 2020 in Review
Dorsey Wright & Associates sold out of Anterix (ATEX) in Q3 2020, closing a stake of 227 shares — an estimated $10K sold.
Dorsey Wright & Associates first reported a position in ATEX in Q4 2018 and held it in 7 quarters. The position peaked at $15K in Q4 2018. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.
- Dorsey Wright & Associates reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
- Dorsey Wright & Associates sold 227 Anterix shares in Q3 2020, an estimated $10K.
- Dorsey Wright & Associates first reported a position in Anterix in Q4 2018 and held it in 7 quarters.
- Dorsey Wright & Associates's Anterix position peaked at $15K in Q4 2018.
- 96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.
Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.